About Azovas (Azelnidipine)
Azovas ( Azelnidipine) is a third-generation calcium channel blocker and is used in the treatment of Hypertension. Azovas is marketed by J.B. Chemicals & Pharmaceuticals Ltd. and comes in two doses namely Azovas 8 mg and Azovas 16 mg.
Azelnidipine is a dihydropyridine calcium channel blocker and is known to be less susceptible to hepatic first-pass effect and its antihypertensive effect is slow sustained. This drug expresses hypotensive action by L-type and T-type Ca+ channel antagonism and blood vessels dilation.
Offers potent & sustained BP control for 24 Hrs . . .
Increase in heart rate leads to Increase in CVD mortality risk . . .
Aldosterone adversely affects the risk of cardiovascular events1 . . .
Prevents Aldosterone Escape 2
No data available for Aldosterone Escape
Safe to be used in Hypertensive patients With Diastolic Dysfunction. . .
In Primary/Essential Hypertension
All ARB + CCB combinations are not the same . . .
Choose the right CCB in ARB + CCB combination. . . .
|CBP & LVMI Reduction||Better than Amlodipine||Yes|
|Aldosterone Escape Prevention||Yes||Not adequate|